Cagle Gerald D. 4
4 · Clearside Biomedical, Inc. · Filed Jun 21, 2018
Insider Transaction Report
Form 4
Cagle Gerald D.
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-20+11,250→ 11,250 totalExercise: $10.74Exp: 2028-06-19→ Common Stock (11,250 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2019.